{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:08:04Z","timestamp":1780376884700,"version":"3.54.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Rehabil. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to systematically review non-pharmacological therapies for patients with lymphangioleiomyomatosis (LAM), and synthesize the effects of non-pharmacological therapies on 6-minute walking distance test (6MWDT), pulmonary function (FEV\u2081), and quality of life in LAM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The systematic review and meta-analysis design was used. Data were searched on Scopus, Web of Science, PubMed, Embase, OVID, CINAHL, CNKI and Wang Fang for studies published from August 2015 to August 2025 on non-pharmacological therapies for patients with LAM. Studies were screened using rigorous inclusion and exclusion criteria. Study quality was assessed using JBI study quality evaluation tools, and a stratified narrative synthesis was conducted based on intervention types, supplemented with a meta-analysis (excluding single-case report).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five studies were eligible to be included in this study. Narrative synthesis showed that interventions with multicomponent, including high intensity aerobic and strength training, yoga, pulmonary rehabilitation and telemonitoring exercise, are beneficial for patients with LAM. Meta-analysis results (excluding the case report) showed that non-pharmacological therapies, particularly structured exercise programs, significantly increased physical activity tolerance of patients with LAM (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.00001) by 37.39 meters using 6MWDT, compared to the pre-intervention or comparison group (95% CI: 27.29, 46.98). Non-pharmacological therapies increased pulmonary function FEV\u2081 (MD: 0.20, 95% CI: \u22120.02, 0.42) and quality of life (SMD: \u22120.19; 95%CI: \u22120.56, 0.18) of the patients with LAM, compared to the pre-intervention or comparison group, however, the results were not significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.08 and 0.32, respectively). No serious adverse events were reported in the included studies, indicating good safety of non-pharmacological interventions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Non-pharmacological therapies, especially physiotherapy, can improve patients with LAM's physical activity tolerance, enhancing their physical fitness and daily activity capacity. Compared with other alveolar and parenchymal diseases (e.g., tuberculosis, COPD), LAM patients show similar improvements in exercise tolerance but less significant improvements in lung function, which may be related to the unique cystic lung pathology of LAM. More effectively and innovatively designed research is needed to improve patients with LAM's pulmonary function and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study not only demonstrates the potential value of non-pharmacological therapies in the management of patients with LAM, but also points the directions for future research. By further optimizing the interventions and expanding the sample size, we can achieve a comprehensive understanding of the long-term effects of non-pharmacological therapies in patients with LAM, eventually providing more effective treatment options for patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , PROSPERO system ID: CRD42024548486.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fresc.2026.1819549","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:28:14Z","timestamp":1780374494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-pharmacological therapies for patients with lymphangioleiomyomatosis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"7","author":[{"given":"Yingwen","family":"Yu","sequence":"first","affiliation":[{"name":"First Affiliated Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lei","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Minnesota Twin Cities","place":["Minneapolis, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Wang","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Guangzhou Medical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"B1","author":"Khaddour","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0973-6131.85485","article-title":"Exploring the therapeutic effects of yoga and its ability to increase quality of life","volume":"4","author":"Woodyard","year":"2011","journal-title":"Int. J. Yoga"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American thoracic society\/European respiratory society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"Spruit","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American thoracic society\/Japanese respiratory society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory society guidelines for the diagnosis and management of lym-phangioleiomomatosis","volume":"35","author":"Johnson","year":"2010","journal-title":"Eur. Respir. J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","article-title":"Use of variability in national and regional data to estimate the prevalence of lymphangioleiomomatosis","volume":"104","author":"Harknett","year":"2011","journal-title":"QJM"},{"key":"B7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1378\/chest.12-2813","article-title":"Lymphangioleiomyomatosis screening in women with tuberous sclero-sis","volume":"144","author":"Cudzilo","year":"2013","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12931-022-02079-6","article-title":"Long-Term clinical course and outcomes in patients with lymphangioleiomyomatosis","volume":"23","author":"Yoon","year":"2022","journal-title":"Respir. Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13023-021-01974-3","article-title":"A population-based study to estimate survival and standardized mortality of tuberous sclerosis Complex (TSC) in Taiwan","volume":"16","author":"Peng","year":"2021","journal-title":"Orphanet J. Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","article-title":"Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management","volume":"196","author":"Gupta","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva","year":"2015","journal-title":"Clin Epidemi-ol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12931-020-1316-3","article-title":"The efficacy and safety of pharmacological treatments for lymphangioleiomyomato-sis","volume":"21","author":"Wang","year":"2020","journal-title":"Respir. Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.12703\/P6-116","article-title":"Management of lymphangioleiomyomatosis","volume":"6","author":"Taveira-DaSilva","year":"2014","journal-title":"F1000 Prime Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu","year":"2010","journal-title":"Lymphat. Res. Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13023-018-0874-7","article-title":"The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis","volume":"13","author":"Gao","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B16","first-page":"16","article-title":"Randomised controlled trials of complex interventions and large-scale transformation of services","volume-title":"Health Serv. Deliv. Res.","author":"Barratt","year":"2016"},{"key":"B17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5603\/ARM.a2020.0129","article-title":"High-Intensity exercise improves pulmonary function and exercise tolerance in a patient with TSC-LAM","volume":"88","author":"Lowder","year":"2020","journal-title":"Adv. Respir. Med"},{"key":"B18","article-title":"Chapter 3: systematic reviews of effectiveness","volume-title":"JBI Manual for Evidence Synthesis","author":"Tufanaru","year":"2020"},{"key":"B19","article-title":"Systematic reviews of etiology and risk, 2020","volume-title":"JBI Manual for Evidence Synthesis","author":"Moola","year":"2024"},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","article-title":"Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation","volume":"13","author":"Lockwood","year":"2015","journal-title":"Int. J. Evid.-Based Healthc"},{"key":"B21","volume-title":"Review Manager (RevMan) [Computer Program], Version 5.4","year":"2020"},{"key":"B22","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions, Version 6.3","author":"Higgins","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B24","doi-asserted-by":"publisher","first-page":"k4817","DOI":"10.1136\/bmj.k4817","article-title":"When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation","volume":"364","author":"Murad","year":"2019","journal-title":"Br Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-Analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/annonc\/mdx064","article-title":"Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes","volume":"28","author":"Bell","year":"2017","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic Re-views","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1183\/13993003.01683-2015","article-title":"Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial","volume":"47","author":"Araujo","year":"2016","journal-title":"Eur. Respir. J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"107397","DOI":"10.1016\/j.rmed.2023.107397","article-title":"A remote monitoring-enabled home exercise prescription for patients with interstitial lung disease at risk for exercise-induced desaturation","volume":"218","author":"Child","year":"2023","journal-title":"Respir. Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13023-020-1344-6","article-title":"Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandom-ized controlled study","volume":"15","author":"Li","year":"2020","journal-title":"Orphanet J. Rare Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-020-01540-3","article-title":"Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomy-omatosis (LAM) compared with COPD: a retrospective analysis","volume":"15","author":"Gloeckl","year":"2020","journal-title":"Orphanet J. Rare Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1590\/S1516-31802009000500016","article-title":"Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease","volume":"127","author":"Puhan","year":"2010","journal-title":"Sao Paulo Med J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1249\/mss.0b013e3180616b27","article-title":"Physical activity and public health: updated recommendation for adults from the American college of sports medicine and the American Heart Association","volume":"39","author":"Haskell","year":"2007","journal-title":"Med. Sci. Sports Exerc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"CD003793","DOI":"10.1002\/14651858.CD003793.pub3","article-title":"Pulmonary rehabilitation for chronic obstructive pulmonary disease","volume":"2015","author":"McCarthy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"CD006322","DOI":"10.1002\/14651858.CD006322.pub4","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1802184","DOI":"10.1183\/13993003.02184-2018","article-title":"Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae","volume":"53","author":"Visca","year":"2019","journal-title":"Eur Respir J"}],"container-title":["Frontiers in Rehabilitation Sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fresc.2026.1819549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:28:16Z","timestamp":1780374496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fresc.2026.1819549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":36,"alternative-id":["10.3389\/fresc.2026.1819549"],"URL":"https:\/\/doi.org\/10.3389\/fresc.2026.1819549","relation":{},"ISSN":["2673-6861"],"issn-type":[{"value":"2673-6861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"1819549"}}